1. Home
  2. MSBI vs KMDA Comparison

MSBI vs KMDA Comparison

Compare MSBI & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSBI
  • KMDA
  • Stock Information
  • Founded
  • MSBI 1881
  • KMDA 1990
  • Country
  • MSBI United States
  • KMDA Israel
  • Employees
  • MSBI N/A
  • KMDA N/A
  • Industry
  • MSBI Major Banks
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSBI Finance
  • KMDA Health Care
  • Exchange
  • MSBI Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • MSBI 437.3M
  • KMDA 413.4M
  • IPO Year
  • MSBI 2016
  • KMDA N/A
  • Fundamental
  • Price
  • MSBI $19.97
  • KMDA $6.94
  • Analyst Decision
  • MSBI Hold
  • KMDA Strong Buy
  • Analyst Count
  • MSBI 4
  • KMDA 2
  • Target Price
  • MSBI $27.75
  • KMDA $14.50
  • AVG Volume (30 Days)
  • MSBI 95.5K
  • KMDA 154.6K
  • Earning Date
  • MSBI 01-23-2025
  • KMDA 03-05-2025
  • Dividend Yield
  • MSBI 6.20%
  • KMDA N/A
  • EPS Growth
  • MSBI N/A
  • KMDA 124.29
  • EPS
  • MSBI N/A
  • KMDA 0.27
  • Revenue
  • MSBI $170,129,000.00
  • KMDA $158,380,000.00
  • Revenue This Year
  • MSBI N/A
  • KMDA $15.37
  • Revenue Next Year
  • MSBI $0.14
  • KMDA $8.58
  • P/E Ratio
  • MSBI N/A
  • KMDA $26.49
  • Revenue Growth
  • MSBI N/A
  • KMDA 4.52
  • 52 Week Low
  • MSBI $19.75
  • KMDA $4.74
  • 52 Week High
  • MSBI $28.10
  • KMDA $8.00
  • Technical
  • Relative Strength Index (RSI)
  • MSBI 26.97
  • KMDA 55.65
  • Support Level
  • MSBI $19.75
  • KMDA $6.90
  • Resistance Level
  • MSBI $25.05
  • KMDA $7.56
  • Average True Range (ATR)
  • MSBI 0.72
  • KMDA 0.34
  • MACD
  • MSBI -0.28
  • KMDA -0.02
  • Stochastic Oscillator
  • MSBI 5.16
  • KMDA 32.68

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: